Cargando…

Monoclonal Antibodies and Multiple Myeloma: All in All It's Just Another Brick in the Wall?

This commentary offers insight about the recent review by the European Medicines Agency on the approval of daratumumab for the treatment of adult patients with multiple myeloma.

Detalles Bibliográficos
Autor principal: Musto, Pellegrino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947460/
https://www.ncbi.nlm.nih.gov/pubmed/29700211
http://dx.doi.org/10.1634/theoncologist.2018-0097

Ejemplares similares